Beranda › Kanker Lambung › Pennsylvania › Philadelphia
Uji klinis Kanker Lambung di Philadelphia, PA
15 studi untuk Kanker Lambung mencari peserta di lokasi sekitar Philadelphia (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Menerima pesertaSukarelawan sehat diterima
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi jauhnya
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mi jauhnya
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 22 mi jauhnya
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Menerima pesertaFase 1
- Sidney Kimmell Cancer Center - Jefferson Health, Philadelphia
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Menerima pesertaFase 2/3
- Alliance Cancer Specialists, PC, Wynnewood · 7 mi jauhnya
- Alliance Cancer Specialists, PC, Media · 12 mi jauhnya
- Alliance Cancer Specialists, PC, Horsham · 16 mi jauhnya
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Menerima pesertaFase 1
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Prehabilitation in High-risk Oncologic Surgery
Menerima peserta
- Fox Chase Cancer Center - Philadelphia, Philadelphia
Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
Menerima pesertaFase 1
- Fox Chase Cancer Center, Philadelphia
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Menerima pesertaFase 3
- University of Pennsylvania, Perelman School of Medicine, Philadelphia
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Menerima pesertaFase 3
- Research Site, Philadelphia
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Menerima pesertaFase 1/2
- University of Pennsylvania, Philadelphia
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Menerima pesertaFase 1/2
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
CTNNA1 Familial Expansion Study
Menerima pesertaStudi observasional
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
Menerima pesertaFase 1/2
- University of Pennsylvania, Philadelphia
Adaptive Radiation for Abdominopelvic Metastases
Menerima pesertaFase 1
- Fox Chase Cancer Center, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Philadelphia
Uji klinis Kanker Lambung di kota lain
- Houston, TX42 studi
- Boston, MA32 studi
- New York City, NY31 studi
- Nashville, TN28 studi
- Baldwin Park, CA22 studi
- Los Angeles, CA22 studi
- Arlington, VA20 studi
- Dallas, TX19 studi
- San Antonio, TX19 studi
- Grand Rapids, MI18 studi
- St. Louis, MO18 studi
- Chicago, IL16 studi
Studi lain di Philadelphia
- Kanker (semua jenis)59 studi
- Kanker Payudara56 studi
- Kanker Paru Non-Sel Kecil51 studi
- Kanker Metastatik46 studi
- Kanker Prostat44 studi
- Kanker Kolorektal44 studi
- Kanker Ovarium44 studi
- Kanker Paru36 studi
- Leukemia Mieloid Akut34 studi
- Gagal Jantung31 studi
- Kanker Endometrium28 studi
- Depresi26 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.